Analyst Price Target is $6.00
▲ +145.90% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Marpai in the last 3 months. The average price target is $6.00, with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 145.90% upside from the last price of $2.44.
Current Consensus is
Buy
The current consensus among 1 contributing investment analysts is to buy stock in Marpai. This Buy consensus rating has held steady for over two years.
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services. It also develops artificial intelligence and healthcare technology. Marpai, Inc. was incorporated in 2021 and is headquartered in New York, New York.
Read More